Public policy statement on opioid antagonist agent detoxification under sedation or anesthesia (OADUSA). American Society of Addiction Medicine (ASAM).
D018686:Anesthetics, Intravenous / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008658:Inactivation, Metabolic; D009292:Narcotic Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000628:therapy*; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*
D018686:Anesthetics, Intravenous; D006993:Hypnotics and Sedatives; D009292:Narcotic Antagonists